Prostatis Group’s GE Vernova GEV Stock Holding History

Prostatis Group’s Portfolio GEV Stock Details GEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$281K	Buy	322 +9	+3%	+$7.02K	0.07%	147
2025 Q4	$204K	Buy	+313	New	+$191K	0.05%	161

Other funds holding GEV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prostatis Group's GEV Position: Q1 2026 in Review

Prostatis Group increased its GE Vernova (GEV) stake by 2.9% in Q1 2026, buying an estimated $7.02K and bringing the position to 322 shares worth $281K. The position accounts for 0.07% of the portfolio, ranked #147.

Prostatis Group first reported a position in GEV in Q4 2025 and has held it in 2 quarters since. 3,117 funds tracked by Wall St. Rank hold GEV as of Q1 2026.

Prostatis Group held 322 shares of GE Vernova worth $281K as of Q1 2026.
Prostatis Group bought 9 GE Vernova shares in Q1 2026, an estimated $7.02K.
GE Vernova made up 0.07% of Prostatis Group's portfolio in Q1 2026, its #147 holding.
Prostatis Group first reported a position in GE Vernova in Q4 2025 and has held it in 2 quarters since.
3,117 funds tracked by Wall St. Rank held GE Vernova as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.